← Leaderboards
Margaret Kathleen Callahan
Sloan-Kettering Inst Can Research
$1,119,468
Attributed
$1,119,468
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $566.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,119,468 · 1
By mechanism
R01$1,119,468 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Michelle S Bradbury$7,087,200
- Timothy An-Thy Chan$21,076,830
- Milind Rajadhyaksha$15,078,152
- Tomas Kirchhoff$7,026,619
- Ulrich Wiesner$4,616,977
Others in their field
Other Rising Stars on “Antibodies”
- Jason Dickens · Duke University$12,259,409
- Jeff T Hutchins · Inhalon Biopharma, Inc.$11,188,896
- Robert C Alexander · Banner Health$8,197,111
- Shaunna Shen · Duke University$7,747,008
- Li Liang · University Of California-Irvine$7,511,446
- Bruxanne El-Kammash · University Of Chicago$7,281,050
Research focus
AntibodiesAntigensAntitumor ResponseAnti-Ctla4Biological MarkersBiomarker DiscoveryBiopsyBloodBiobankCancer BiomarkersCancer TherapyCancer TypeCd8-Positive T-LymphocytesCellsClinical BiomarkersClinical DataClinical DevelopmentClinical OncologyClinical TrialsBlood SpecimenCostData SetDisorder ControlEffectiveness
Grant awards (3)
Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance$552,595
R01 · FY2025 · CA · contact PI
Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance$527,057
R01 · FY2023 · CA · contact PI
Understanding Immunotype, a Novel Biomarker for Checkpoint Blockade Resistance$39,816
R01 · FY2023 · CA · contact PI